PetVivo Holdings Inc (PETV)

Healthcare | Medical Devices
Income Statement (Quarterly) 2025-06-30 2024-12-31 2024-09-30 2024-06-30
Revenue 297,500 583,313 200,720 123,751
Cost of Revenue 110,774 61,497 21,162 12,994
Gross Profit 186,726 521,816 179,558 110,757
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 1,690,530 1,908,268 1,887,424 1,767,674
Operating Expenses 2,031,043 2,280,221 2,352,598 2,155,189
Operating Income -1,844,317 -1,758,405 -2,173,040 -2,044,432
Interest Expense 121,808 24,378 0 2,631
Income Before Tax -2,311,037 -1,757,038 -2,175,493 -2,047,063
Income Tax Expense 0 0 0 0
Net Income -2,311,037 -1,757,038 -2,175,493 -2,047,063
Per Share
EPS -0.09 -0.09 -0.11 -0.11
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Revenue 1,132,533 968,706 917,162 115,586 12,578
Cost of Revenue 137,677 229,180 526,817 201,154 10,695
Gross Profit 994,856 739,526 390,345 -85,568 1,883
Operating Expenses
R&D Expenses 0 0 0 0 0
SG&A Expenses 7,467,325 10,092,852 8,433,220 4,496,079 1,862,641
Operating Expenses 9,050,576 11,360,866 9,123,797 4,970,960 1,960,871
Operating Income -8,055,720 -10,621,340 -8,733,452 -5,056,528 -1,958,988
Interest Expense 359,408 0 0 -41,533 228,595
Income Before Tax -8,399,166 -10,955,295 -8,717,608 -5,014,995 -3,522,780
Income Tax Expense 0 0 -15,844 -73,213 0
Net Income -8,399,166 -10,955,295 -8,701,764 -4,941,782 -3,522,780
Per Share
EPS -0.41 -0.78 -0.85 -0.56 -0.57
EPS Diluted 0.00 0.00 0.00 0.00 0.00
Balance Sheet (Quarterly) 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Assets
Cash and Cash Equivalents 227,689 87,403 475,314 6,106,827
Short Term Investments 150,000 0 0 0
Net Receivables 4,460,573 18,669 86,689 2,596
Inventory 323,504 390,076 370,283 98,313
Total Current Assets 5,609,567 1,041,660 1,423,980 6,755,400
Property Plant Equipment 1,728,413 2,016,004 948,833 610,650
Goodwill and Intangibles 1,973,725 30,099 38,649 48,452
Total Assets 9,339,195 3,115,253 2,438,952 7,427,332
Liabilities
Account Payables 821,081 821,230 588,713 323,384
Short Term Debt 2,099,076 348,110 85,085 65,727
Total Current Liabilities 4,316,800 1,412,370 1,453,680 1,173,486
Long Term Debt 803,147 1,016,930 260,247 267,124
Total Liabilities 5,119,947 2,429,300 1,713,927 1,440,610
Shareholders Equity
Retained Earnings -91,198,490 -82,799,324 -71,844,029 -63,126,421
Total Shareholders Equity 4,219,248 685,953 725,025 5,986,722
Balance Sheet (Annual) 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Assets
Cash and Cash Equivalents 227,689 87,403 475,314 6,106,827 23,578
Short Term Investments 150,000 0 0 0 0
Net Receivables 4,460,573 18,669 86,689 2,596 0
Inventory 323,504 390,076 370,283 98,313 0
Total Current Assets 5,609,567 1,041,660 1,423,980 6,755,400 147,153
Property Plant Equipment 1,728,413 2,016,004 948,833 610,650 371,798
Goodwill and Intangibles 1,973,725 30,099 38,649 48,452 27,932
Total Assets 9,339,195 3,115,253 2,438,952 7,427,332 835,247
Liabilities
Account Payables 821,081 821,230 588,713 323,384 770,076
Short Term Debt 2,099,076 348,110 85,085 65,727 405,355
Total Current Liabilities 4,316,800 1,412,370 1,453,680 1,173,486 1,405,048
Long Term Debt 803,147 1,016,930 260,247 267,124 327,178
Total Liabilities 5,119,947 2,429,300 1,713,927 1,440,610 1,732,226
Shareholders Equity
Retained Earnings -91,198,490 -82,799,324 -71,844,029 -63,126,421 -58,111,426
Total Shareholders Equity 4,219,248 685,953 725,025 5,986,722 -896,979
Cash Flow Statement (Quarterly) 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Operating Activities
Net Income -8,399,166 -10,955,295 -8,717,608 -5,014,995
Depreciation & Amortization 353,213 126,850 114,434 65,153
Stock Based Compensation 1,480,770 2,630,599 1,462,768 702,896
Change in Working Capital 277,809 171,635 -161,677 -200,511
Operating Cash Flow -5,321,953 -7,419,588 -6,794,483 -4,174,957
Investing Activities
Capital Expenditure -563,434 -309,104 -423,934 -183,184
Investments -63,434 0 -423,934 -183,184
Investing Cash Flow -563,434 -309,104 -423,934 -183,184
Financing Activities
Debt Repayment 2,157,573 813,342 -6,399 -81,685
Common Stock Issued/Repurchased 2,050,100 6,527,439 1,526,745 10,200,881
Dividends Paid 0 0 0 0
Financing Cash Flow 6,025,673 7,340,781 1,586,904 10,441,390
Summary
Free Cash Flow -5,885,387 -7,728,692 -7,218,417 -4,358,141
Net Change in Cash 140,286 -387,911 -5,631,513 6,083,249
Cash Flow Statement (Annual) 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Operating Activities
Net Income -8,399,166 -10,955,295 -8,717,608 -5,014,995 -3,522,780
Depreciation & Amortization 353,213 126,850 114,434 65,153 86,712
Stock Based Compensation 1,480,770 2,630,599 1,462,768 702,896 452,674
Change in Working Capital 277,809 171,635 -161,677 -200,511 -114,935
Operating Cash Flow -5,321,953 -7,419,588 -6,794,483 -4,174,957 -1,047,329
Investing Activities
Capital Expenditure -563,434 -309,104 -423,934 -183,184 -160,164
Investments -63,434 0 -423,934 -183,184 -140,685
Investing Cash Flow -563,434 -309,104 -423,934 -183,184 -160,164
Financing Activities
Debt Repayment 2,157,573 813,342 -6,399 -81,685 -19,673
Common Stock Issued/Repurchased 2,050,100 6,527,439 1,526,745 10,200,881 368,500
Dividends Paid 0 0 0 0 0
Financing Cash Flow 6,025,673 7,340,781 1,586,904 10,441,390 1,220,489
Summary
Free Cash Flow -5,885,387 -7,728,692 -7,218,417 -4,358,141 -1,207,493
Net Change in Cash 140,286 -387,911 -5,631,513 6,083,249 12,996